Gemcitabine in Treating Children With Refractory Solid Tumors

NCT00005577 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

30

Enrollment

NIH

Sponsor class

Conditions

Unspecified Childhood Solid Tumor, Protocol Specific

Interventions

DRUG: gemcitabine hydrochloride

Sponsor

National Cancer Institute (NCI)